ACTH Treatment of APOL1- Associated Nephropathy
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2016
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Kidney disorders; Proteinuria
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment due to no enrolment occurred.
- 10 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.